Prime Medicine Inc [PRME] Records 200-Day SMA of $8.71
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine
Prime Medicine Inc’s filing revealed that its 10% Owner ARCH Venture Partners XII, LLC acquired Company’s shares for reported $20.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Prime Medicine Inc’s filing revealed that its 10% Owner ARCH Venture Partners XII, LLC acquired Company’s shares for reported $20.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Prime Medicine
Prime Medicine Inc’s filing revealed that its 10% Owner ARCH Venture Partners XII, LLC acquired Company’s shares for reported $20.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Prime Medicine Inc’s recently made public that its 10% Owner ARCH Venture Partners XII, LLC acquired Company’s shares for reported